Latest Strategy News

Prairie Lithium has locked in a decade-long agreement to supply lithium-bearing crystallite to Hydro Lithium’s South Korean refinery, marking a strategic step in its commercial-scale production and market entry.

The ACCC has opposed IAG’s proposed acquisition of RAC Insurance in Western Australia, citing concerns it would stifle competition and lead to higher premiums and reduced product quality.

Jade Gas Holdings has verified exceptionally high methane purity exceeding 97% at its Red Lake gasfield, underpinning its commercial LNG ambitions and opening new chemical feedstock opportunities.

Axiom Properties, soon to be Axtec Limited, has forged a strategic partnership with Ray White Avi Khan Group to deploy cutting-edge embedded payments and automation solutions across 3,000 properties, aiming to transform real estate transactions and boost recurring revenue.

Legacy Minerals Holdings has identified promising new silver targets at its Mt Carrington Project in NSW, securing approvals for an additional 3,500 metres of drilling to expand its substantial 115Moz silver equivalent resource.

Lightning Minerals Ltd is set to launch a fully funded Phase 2 drilling campaign at its Mt Turner Gold Project in Queensland, following Phase 1 success that revealed a large mineralised system along a 12km strike of the Drummer Fault.

Beetaloo Energy has reached a Final Investment Decision for its Carpentaria Pilot Project, paving the way for gas sales from EP187 starting in 2026. This milestone follows key agreements and approvals, marking a significant step in Northern Territory’s energy development.

Amaero Ltd has secured a substantial A$9 million saving on its Argon recycling plant, ordered a fourth atomizer to boost U.S. powder production, and remains on track with its A$72 million capital investment program.

Norwest Minerals updates its West Arunta exploration strategy following a doubling of silver prices and a high-grade discovery at Dales Gossan, setting the stage for a major 2026 drilling campaign.

Myer Holdings Limited reported steady FY25 financial results with $4.076 billion in sales and outlined ambitious growth strategies at its Annual General Meeting, alongside key director re-elections and executive incentives.

Neurizon Therapeutics has secured FDA clearance for its lead drug candidate NUZ-001 to enter the HEALEY ALS Platform Trial, marking a key regulatory milestone and setting the stage for patient enrollment in early 2026.

Intelligent Monitoring Group has agreed to acquire Tyco NZ and Red Wolf for NZD 45 million, significantly boosting its New Zealand presence and FY26 earnings outlook.